Treatment of thrush in oncology patients Journal Article

  


Author: Polsky, B.
Article Title: Treatment of thrush in oncology patients
Abstract: The oral cavity is a common site for fungal infections, especially candidiasis, in patients with hematologic neoplasms and those treated with chemotherapy. Clinical experience at Memorial Sloan-Kettering Cancer Center has shown that a program combining good oral care and antifungal therapy is effective in this patient population. Local therapy is recommended for mild to moderate disease. Azoles are used with more serious infection and low-dose amphotericin B is instituted when azole resistance is seen. The use of systemic antifungal agents for the prevention of infection is questionable since the cost of oral azoles may be prohibitive and azole-resistant oral candidiasis has become increasingly common. Oral amphotericin B, however, may offer a new choice for prophylaxis.
Keywords: cancer chemotherapy; leukemia; drug efficacy; conference paper; oncology; ketoconazole; fluconazole; candidiasis; mycosis; itraconazole; oral drug administration; flucytosine; mouth hygiene; local treatment; nystatin; thrush; amphotericin b; topical drug administration; clotrimazole; mouth infection; cancer; human; pyrrole; azole resistance
Journal Title: Journal de Mycologie Médicale
Volume: 6
Issue: Suppl. 2
ISSN: 1156-5233
Publisher: Elsevier Masson  
Date Published: 1996-01-01
Start Page: 20
End Page: 23; discussion 23-25
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030476266&partnerID=40&md5=57e32a6aa1dd53f14ab2ed8f38800d2e
Notes: Conference Paper -- Export Date: 22 November 2017 -- Source: Scopus